These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 20584621)

  • 1. Epigenetics in pain and analgesia: an imminent research field.
    Doehring A; Geisslinger G; Lötsch J
    Eur J Pain; 2011 Jan; 15(1):11-6. PubMed ID: 20584621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM; Borlak J
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in C. elegans: facts and challenges.
    Wenzel D; Palladino F; Jedrusik-Bode M
    Genesis; 2011 Aug; 49(8):647-61. PubMed ID: 21538806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone modifications as a platform for cancer therapy.
    Espino PS; Drobic B; Dunn KL; Davie JR
    J Cell Biochem; 2005 Apr; 94(6):1088-102. PubMed ID: 15723344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of lung cancer.
    Bowman RV; Yang IA; Semmler AB; Fong KM
    Respirology; 2006 Jul; 11(4):355-65. PubMed ID: 16771905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in cancer.
    Banerjee HN; Verma M
    Biomark Med; 2009 Aug; 3(4):397-410. PubMed ID: 20477485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction into the analysis of high-throughput-sequencing based epigenome data.
    Huss M
    Brief Bioinform; 2010 Sep; 11(5):512-23. PubMed ID: 20457755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic control.
    Delcuve GP; Rastegar M; Davie JR
    J Cell Physiol; 2009 May; 219(2):243-50. PubMed ID: 19127539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The next innovation cycle in toxicogenomics: environmental epigenetics.
    Reamon-Buettner SM; Mutschler V; Borlak J
    Mutat Res; 2008; 659(1-2):158-65. PubMed ID: 18342568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
    Geiman TM; Robertson KD
    J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics primer: why the clinician should care about epigenetics.
    Duarte JD
    Pharmacotherapy; 2013 Dec; 33(12):1362-8. PubMed ID: 23864439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.